✦ LIBER ✦

6534 POSTER Elevated levels of thioredoxin (Trx) in serum correlate with poor outcome in docetaxel (doc)/cisplatin (cis)-treated stage IV non-small-cell lung cancer (NSCLC) patients (pts)

✍ Scribed by Molina, M.A.; Camps, C.; DelasPeñas, R.; Alonso, G.; Lopez-Vivanco, G.; Provencio, M.; González-Larriba, J.L.; Salazar, F.; Sánchez, J.J.; Rosell, R.

Book ID: 122917062
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 60 KB
Volume: 5
Category: Article
ISSN: 1359-6349
DOI: 10.1016/S1359-6349(07)71362-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-205 Lack of b-tubulin gene mutations i

P-205 Lack of b-tubulin gene mutations in docetaxel (doc)/cisplatin (cis)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p) at time of tumor progression

✍ Queralt, Cristina; Roig, Barbara; Sarries, Carme; Botia, Monica; Nun˜ez, Laura; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 233 KB

O-089 ERCC1 mRNA-based randomized phase

O-089 ERCC1 mRNA-based randomized phase III trial of docetaxel (doc) doublets with cisplatin (cis) or gemcitabine (gem) in stage IV non-small-cell lung cancer (NSCLC) patients (p)

✍ Cobo, M.; Isla, D.; Sánchez, J.; Massuti, B.; Montes, A.; Paz-Ares, L.; Múñoz, M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

6528 POSTER Role of ERCC1, XRCC3, Aurora

6528 POSTER Role of ERCC1, XRCC3, Aurora A and TGFBR1 gene single nucleotide polymorphisms (SNP) and CHFR and 14-3-3s methylation in a customized cisplatin (cis) trial based on ERCC1 mRNA levels in stage IV non-small-cell lung cancer (NSCLC) patients (pts)

✍ Taron, M.; Cobo, M.; Isla, L.; Massuti, B.; Montes, A.; Sanchez, J.M.; Botia, M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB